Poor response to anti-anemia drug linked to heart disease riskDecember 29th, 2010 - 4:48 pm ICT by ANI
Washington, Dec 29 (ANI): Scientists at UT Southwestern Medical Center have found that patients with diabetes, kidney disease and anemia who don’t respond to treatment with an anti-anemia drug have a higher risk of cardiovascular disease or death.
The findings suggest that testing such patients’ responsiveness to the drug and keeping blood iron levels a little low might reduce their risk, said Robert Toto, senior author of the study.
The results were an unexpected finding of a study on darbepoetin alpha, which stimulates the production of red blood cells to counteract anemia.
The study showed that darbepoetin alpha works no better than a placebo for improving cardiovascular and kidney outcomes, but it did lower the risk for blood transfusion and resulted in modest improvement in patient-reported outcomes among people with diabetes, kidney disease and anemia.
However, people receiving darbepoetin alpha had nearly a twofold higher risk for stroke. Cancer deaths were also higher among people receiving the drug.
The study included 4,038 participants, all of whom had type 2 diabetes, anemia and kidney damage, although not enough to require dialysis. Of these, 1,872 received injections of the drug, and 1,889 received placebo injections.
Participants receiving darbepoetin alpha also received periodic subcutaneous injections of the drug with the aim of increasing their levels of hemoglobin to a level of 13 grams per deciliter.
In analyzing the results, the researchers found that the participants who had poor initial responses to the drug had a higher rate of death, heart attack, stroke or heart failure.
Conversely, for patients who respond quickly to the drug appears safer, Toto said.
The findings appeared in the New England Journal of Medicine. (ANI)
- Anaemia drug doesn't benefit kidney disease patients - Dec 23, 2009
- B vitamin therapy leads to kidney function decline in kidney disease patients - Apr 28, 2010
- Blood protein levels may predict risk of heart disease - Apr 09, 2011
- Tool predicts death probability from stroke - Feb 11, 2011
- Drugs combo 'yields up to nearly 10 pc weight loss' - Apr 11, 2011
- New test detects kidney disorder early - Aug 06, 2011
- Common painkillers increase risk of heart problems: Study - Jan 12, 2011
- Benefits of intensive glucose treatment must be weighed against risks - Jun 30, 2010
- Dark chocolate reduces risk of cardiac fatalities - Jun 04, 2012
- New drug limits brain damage in stroke - Jul 27, 2012
- Bariatric surgery cuts long-term cardiovascular risk in diabetics - Mar 31, 2011
- Top 10 major advances in heart disease in 2010 - Dec 22, 2010
- New online tool predicts probability of death in patients after stroke - Feb 11, 2011
- Slightly high BP raises chances of stroke - Sep 29, 2011
- Depression may increase kidney failure risk - Mar 11, 2011
Tags: anemia drug, blood iron levels, blood transfusion, cancer deaths, darbepoetin alpha, deciliter, england journal of medicine, heart disease risk, heart failure, initial responses, kidney damage, kidney disease, new england journal, new england journal of medicine, poor response, production of red blood cells, red blood cells, southwestern medical center, subcutaneous injections, type 2 diabetes